Showing 1 - 20 results of 37 for search 'T. V. Korotaeva', query time: 0.04s Refine Results
  1. 1
    Results of direct comparison of the clinical efficacy of ixekizumab and adalimumab: data from the SPIRIT H2H study

    Results of direct comparison of the clinical efficacy of ixekizumab and adalimumab: data from the SPIRIT H2H study by T. V. Korotaeva

    Published 2020-09-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Results of studying the clinical efficacy and safety of tofacitinib in the treatment of psoriatic arthritis

    Results of studying the clinical efficacy and safety of tofacitinib in the treatment of psoriatic arthritis by T. V. Korotaeva, E. Yu. Loginova

    Published 2019-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Early psoriatic arthritis

    Early psoriatic arthritis by E. Y. Loginova, T. V. Korotaeva

    Published 2008-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Immunopathogenetic mechanisms of action of ustekinumab, a new drug for the treatment of psoriatic arthritis and psoriasis

    Immunopathogenetic mechanisms of action of ustekinumab, a new drug for the treatment of psoriatic arthritis and psoriasis by T. V. Korotaeva, E. Yu. Loginova

    Published 2015-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Clinical experience with apremilast for psoriatic arthritis

    Clinical experience with apremilast for psoriatic arthritis by E. Yu. Loginova, T. V. Korotaeva

    Published 2018-09-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Janus kinase inhibitors in the treatment of psoriatic arthritis

    Janus kinase inhibitors in the treatment of psoriatic arthritis by E. Yu. Loginova, T. V. Korotaeva

    Published 2022-02-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Pharmacoeconomic study of active psoriatic arthritis treatment

    Pharmacoeconomic study of active psoriatic arthritis treatment by A. V. Rudakova, Т. V. Korotaeva

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Experience of guselkumab usage in the treatment of patients with psoriatic arthritis in real clinical practice

    Experience of guselkumab usage in the treatment of patients with psoriatic arthritis in real clinical practice by E. Yu. Loginova, Yu. L. Korsakova, T. V. Korotaeva

    Published 2021-10-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    THE PATTERN OF CARDIOVASCULAR COMORBIDITY IN PATIENTS WITH SEVERE FORMS OF PSORIASIS: DATA OF RETROSPECTIVE ANALYSIS OF A HOSPITAL COHORT

    THE PATTERN OF CARDIOVASCULAR COMORBIDITY IN PATIENTS WITH SEVERE FORMS OF PSORIASIS: DATA OF RETROSPECTIVE ANALYSIS OF A HOSPITAL COHORT by N. V. Batkaeva, T. V. Korotaeva, E. A. Batkaev

    Published 2017-10-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Erelzi<sup>®</sup> – biosimilar of etanercept in the treatment of rheumatic diseases and psoriasis (Resolution of the Expert Panel)

    Erelzi<sup>®</sup> – biosimilar of etanercept in the treatment of rheumatic diseases and psoriasis (Resolution of the Expert Panel) by V. I. Mazurov, A. M. Lila, T. V. Korotaeva

    Published 2021-08-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Pharmacoeconomic aspects of the targeted drugs use in psoriatic arthritis in context of the Russian healthcare system

    Pharmacoeconomic aspects of the targeted drugs use in psoriatic arthritis in context of the Russian healthcare system by O. I. Ivakhnenko, T. V. Korotaeva, T. V. Dubinina, A. M. Lila

    Published 2022-10-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Systematic review and meta-analysis: risk factors for psoriatic arthritis. Part 2

    Systematic review and meta-analysis: risk factors for psoriatic arthritis. Part 2 by N. O. Pereverzina, L. S. Kruglova, T. V. Korotaeva, A. M. Lila

    Published 2022-05-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    The safety and optimal dosage of an interleukin-17A inhibitor (secukinumab) in the treatment of psoriatic arthritis in a patient with concomitant hepatitis C virus infection

    The safety and optimal dosage of an interleukin-17A inhibitor (secukinumab) in the treatment of psoriatic arthritis in a patient with concomitant hepatitis C virus infection by E. E. Gubar, T. V. Korotaeva, A. S. Starkova, M. M. Urumova

    Published 2019-10-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Systematic review and meta-analysis: risk factors for psoriatic arthritis. Part 1.

    Systematic review and meta-analysis: risk factors for psoriatic arthritis. Part 1. by N. O. Pereverzina, L. S. Kruglova, T. V. Korotaeva, A. M. Lila

    Published 2022-02-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Comorbid infections in spondyloarthritis: a modern view of the problem

    Comorbid infections in spondyloarthritis: a modern view of the problem by N. V. Muravyeva, B. S. Belov, M. M. Baranova, T. V. Korotaeva

    Published 2020-11-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Dynamics of Carotid Intima-Media Thickness, Parameters of Arterial Stiffness and Ambulatory Blood Pressure Monitoring during Therapy with Inhibitor of Tumor Necrosis Factor-Alpha in Patients with Early Psoriatic Arthritis

    Dynamics of Carotid Intima-Media Thickness, Parameters of Arterial Stiffness and Ambulatory Blood Pressure Monitoring during Therapy with Inhibitor of Tumor Necrosis Factor-Alpha... by E. I. Markelova, D. S. Novikova, T. V. Korotaeva, E. Yu. Loginova

    Published 2018-11-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    The first results of a 6-year follow-up study of a patient with early psoriatic arthritis treated with a treat-to-target strategy

    The first results of a 6-year follow-up study of a patient with early psoriatic arthritis treated with a treat-to-target strategy by P. O. Tremaskina, E. Yu. Loginova, T. V. Korotaeva, A. V. Sukhinina

    Published 2020-09-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    SYSTEMIC OSTEOPOROSIS AND PSORIATIC ARTHRITIS: CURRENT UNDERSTANDING OF THE PROBLEM

    SYSTEMIC OSTEOPOROSIS AND PSORIATIC ARTHRITIS: CURRENT UNDERSTANDING OF THE PROBLEM by O. V. Dobrovolskaya, N. V. Toroptsova, E. Yu. Loginova, T. V. Korotaeva

    Published 2017-10-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Comorbid infections in patients with spondyloarthritis: frequency, structure and risk factors

    Comorbid infections in patients with spondyloarthritis: frequency, structure and risk factors by M. M. Baranova, N. V. Muravyeva, B. S. Belov, T. V. Korotaeva, S. I. Glukhova

    Published 2023-08-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    15th MEDITERRANEAN RHEUMATOLOGY CONGRESS (ISTANBUL, TURKEY, 28–31 AUGUST 2014)

    15th MEDITERRANEAN RHEUMATOLOGY CONGRESS (ISTANBUL, TURKEY, 28–31 AUGUST 2014) by N. V. Seredavkina, L. N. Denisov, T. V. Korotaeva, L. V. Kondratyeva, M. V. Podryadnova

    Published 2015-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: